![Jeremy Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeremy Levin
Chief Executive Officer at
CERYVYN THERAPEUTICS LIMITED
Net worth: 10 M $ as of 2026-06-29
Profile
Jeremy Max Levin is the founder of Ovid Therapeutics, Inc., founded in 2014, serving as Executive Chairman.
Current jobs include Executive Chairman & Chief Executive Officer at Ceryvyn Therapeutics Ltd. since 2025, Director at Biotechnology Innovation Organization since 2021, and Advisor at New Rhein Healthcare Investors.
Former jobs include President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd. from 2012 to 2013, Chairman & Chief Executive Officer at Cadus Corp.
from 1992 to 1998, Chief Executive Officer at Physiome Sciences, Inc. from 1998 to 2003, Director at ZymoGenetics, Inc. in 2010, Independent Non-Executive Director at Biocon Ltd. from 2015 to 2020, Director at The Biotechnology Institute, Director at New York Biotechnology Association, Inc., Director at ZappRx, Inc., Independent Director at H.
Lundbeck A, SVP-Strategy, Alliances & Transactions at Bristol Myers Squibb Co. from 2007 to 2012, Global Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. from 2002 to 2007, and President at Medarex, Inc. from 2009 to 2011.
Education includes undergraduate and graduate degrees from the University of Oxford, with the undergraduate degree conferred in 1974, and a doctorate from the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-16 | 3,770,509 ( 2.02% ) | 10 M $ | 2026-06-29 | |
| 2026-06-22 | 13,409,685 ( 0.98% ) | 139 327 $ | 2026-06-29 |
Jeremy Levin active positions
| Companies | Position | Start |
|---|---|---|
| OVID THERAPEUTICS INC. | Founder | 2014-03-31 |
| CERYVYN THERAPEUTICS LIMITED | Chief Executive Officer | 2025-08-31 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | 2021-06-13 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Consultant / Advisor | - |
Former positions of Jeremy Levin
| Companies | Position | End |
|---|---|---|
| BIOCON LIMITED | Director/Board Member | 2019-12-31 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Executive Officer | 2013-10-29 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 2006-12-31 |
Physiome Sciences, Inc.
 Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides computer-based modeling and simulation of cells, and biological systems for drug development | President | - |
Training of Jeremy Levin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Cadus Corp.
 Cadus Corp. BiotechnologyHealth Technology Provides drug research services | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biocon Ltd.
 Biocon Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Physiome Sciences, Inc.
Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides computer-based modeling and simulation of cells, and biological systems for drug development | Commercial Services |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Commercial Services |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
- Stock Market
- Insiders
- Jeremy Levin
